Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy (PRECEDENT)
This study has been completed.
Sponsor:
Merck
Information provided by (Responsible Party):
Merck
ClinicalTrials.gov Identifier:
NCT00722592
First received: July 23, 2008
Last updated: March 5, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2012 |
| Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | March 7, 2012 |